Abstract
A 43-year-old woman with Philadelphia chromosome (Ph) positive chronic myelogenous leukemia in acute phase received high-dose chemotherapy followed by transfusion of 12 randomly selected units of umbilical cord blood. HLA analysis showed cells of one donor from day +10 to day +43 post-transfusion. This unit was HLA class II identical with that of the patient.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinreb, S., Delgado, J., Clavijo, O. et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 22, 193–196 (1998). https://doi.org/10.1038/sj.bmt.1701309
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701309
Keywords
This article is cited by
-
Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells
Cardiovascular Drugs and Therapy (2016)
-
Ex vivo expansion of cord blood
Bone Marrow Transplantation (2009)
-
Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML
Bone Marrow Transplantation (2009)